Detalhe da pesquisa
1.
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Blood
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588489
2.
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Blood
; 143(14): 1391-1398, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153913
3.
Overlapping features of therapy-related and de novo NPM1-mutated AML.
Blood
; 141(15): 1846-1857, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508705
4.
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Br J Haematol
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593353
5.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316325
6.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320176
7.
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1.
Blood
; 140(24): 2594-2610, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35857899
8.
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults.
Haematologica
; 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38356450
9.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38654660
10.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer
; 129(7): 1126-1133, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542108
11.
Epidemiology of haemophagocytic lymphohistiocytosis at the population level in Germany.
Br J Haematol
; 201(2): 285-289, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535304
12.
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Haematologica
; 108(3): 690-704, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708137
13.
Impact of trisomy 19 on outcome according to genetic makeup in patients with acute myeloid leukemia.
Haematologica
; 108(8): 2059-2066, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815361
14.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica
; 108(1): 34-41, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678031
15.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood
; 136(7): 823-830, 2020 08 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32496541
16.
High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes.
Br J Haematol
; 192(5): 879-891, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486765
17.
NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia.
Blood
; 134(4): 383-388, 2019 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186273
18.
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Haematologica
; 106(12): 3100-3106, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047178
19.
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Blood
; 141(13): 1640-1644, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450137
20.
Aneuploidy in children with relapsed B-cell precursor acute lymphoblastic leukaemia: clinical importance of detecting a hypodiploid origin of relapse.
Br J Haematol
; 185(2): 266-283, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714092